模拟采用2019年社区获得性肺炎指南对114家退伍军人医疗中心住院患者培养和抗生素选择的影响
该研究模拟在退伍军人事务(VA)医疗中心住院的社区获得性肺炎(CAP)患者中采用2019年ATS/IDSA指南的效果。
要点
- 指南采用将降低病房和ICU中抗MRSA及抗假单胞菌经验性治疗比例。
- 指南采用将减少MRSA和铜绿假单胞菌的过度覆盖,但轻微增加覆盖不足。
- 指南采用将改变血培养和呼吸道培养的送检比例,病房血培养减少,ICU培养增加。
核心结论
- 在VA住院CAP患者中采用2019年指南将大幅改变培养和经验性抗生素选择实践,减少MRSA和铜绿假单胞菌的过度覆盖,但轻微增加覆盖不足。
主要发现
- 指南采用将使病房呼吸道培养比例从30%升至36%,血培养从93%降至36%;ICU呼吸道培养从40%升至100%,血培养从95%升至100%。
- 指南采用将使病房抗MRSA经验性治疗从27%降至1%,ICU从61%降至8%;抗假单胞菌治疗病房从25%降至1%,ICU从54%降至9%。
- MRSA过度覆盖病房从27%降至1%,ICU从56%降至8%;MRSA覆盖不足病房从0.6%升至1.3%,ICU从0.5%升至3.3%;铜绿假单胞菌结果类似。
- 所有比较P < .001。
关键数值与推荐
- 指南推荐调整培养和经验性抗生素策略,模拟显示可大幅减少抗MRSA和抗假单胞菌经验性使用。
临床怎么用
- 临床可参考2019年CAP指南优化培养送检和经验性抗生素选择,以减少不必要的广谱覆盖。
局限性
- 研究为模拟分析,非实际干预,结果可能受指南依从性和患者群体特征影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The 2019 American Thoracic Society/Infectious Diseases Society of America guidelines for community-acquired pneumonia (CAP) revised recommendations for culturing and empiric broad-spectrum antibiotics. We simulated guideline adoption in Veterans Affairs (VA) inpatients. METHODS: For all VA acute hospitalizations for CAP from 2006-2016 nationwide, we compared observed with guideline-expected proportions of hospitalizations with initial blood and respiratory cultures obtained, empiric antibiotic therapy with activity against methicillin-resistant Staphylococcus aureus (anti-MRSA) or Pseudomonas aeruginosa (antipseudomonal), empiric "overcoverage" (receipt of anti-MRSA/antipseudomonal therapy without eventual detection of MRSA/P. aeruginosa on culture), and empiric "undercoverage" (lack of anti-MRSA/antipseudomonal therapy with eventual detection on culture). RESULTS: Of 115 036 CAP hospitalizations over 11 years, 17 877 (16%) were admitted to an intensive care unit (ICU). Guideline adoption would slightly increase respiratory culture (30% to 36%) and decrease blood culture proportions (93% to 36%) in hospital wards and increase both respiratory (40% to 100%) and blood (95% to 100%) cultures in ICUs. Adoption would decrease empiric selection of anti-MRSA (ward: 27% to 1%; ICU: 61% to 8%) and antipseudomonal (ward: 25% to 1%; ICU: 54% to 9%) therapies. This would correspond to greatly decreased MRSA overcoverage (ward: 27% to 1%; ICU: 56% to 8%), slightly increased MRSA undercoverage (ward: 0.6% to 1.3%; ICU: 0.5% to 3.3%), with similar findings for P. aeruginosa. For all comparisons, P < .001. CONCLUSIONS: Adoption of the 2019 CAP guidelines in this population would substantially change culturing and empiric antibiotic selection practices, with a decrease in overcoverage and slight increase in undercoverage for MRSA and P. aeruginosa.
引用
- Christensen MA, Nevers M, Ying J, et al. Simulated Adoption of 2019 Community-Acquired Pneumonia Guidelines Across 114 Veterans Affairs Medical Centers: Estimated Impact on Culturing and Antibiotic Selection in Hospitalized Patients. Clin Infect Dis. 2021. PMID: 33512530. doi:10.1093/cid/ciaa1604
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。